The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
morphosys | 672 |
galapagos | 45 |
roche | 31 |
lonza | 24 |
lanthiopep | 22 |
bayer schering pharma | 21 |
morphosys ip | 6 |
bayer | 5 |
applied nanosystems | 5 |
moll, gert nikolaas | 5 |
morphosys | 58 |
bayer schering pharma | 16 |
gpc biotech | 3 |
lonza | 3 |
roche | 2 |
morphosys ip | 2 |
bayer | 1 |
dyax corporation | 1 |
schering corporation | 1 |
gpc biotech ag;morphosys | 1 |
morphosys | 101 |
galapagos | 24 |
lanthiopep | 2 |
immatics biotechnologies | 1 |
moll, gert nikolaas | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
generation and profiling of fully human hucal gold-derived therapeutic antibodies specif… 🛈 | 45 | 2005 |
anti-cd38 human antibodies and uses therefor | 39 | 2004 |
anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma … 🛈 | 36 | 2010 |
anti-gm-csf antibodies and uses therefor | 30 | 2005 |
treatment for rheumatoid arthritis | 30 | 2012 |
a collection and methods for its use | 29 | 2009 |
combinations and uses thereof | 28 | 2012 |
anti-amyloid beta antibodies and their use | 28 | 2002 |
a collection and methods for its use | 27 | 2010 |
antagonists of il17c for the treatment of inflammatory disorders | 24 | 2011 |